EBS
Price
$6.99
Change
-$0.12 (-1.69%)
Updated
Jul 3 closing price
Capitalization
120.07M
37 days until earnings call
QNTM
Price
$17.06
Change
-$2.10 (-10.96%)
Updated
Jul 3 closing price
Capitalization
57.99M
Interact to see
Advertisement

EBS vs QNTM

Header iconEBS vs QNTM Comparison
Open Charts EBS vs QNTMBanner chart's image
Emergent Biosolutions
Price$6.99
Change-$0.12 (-1.69%)
Volume$917.38K
Capitalization120.07M
Quantum Biopharma
Price$17.06
Change-$2.10 (-10.96%)
Volume$330.02K
Capitalization57.99M
EBS vs QNTM Comparison Chart in %
Loading...
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EBS vs. QNTM commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EBS is a Hold and QNTM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (EBS: $6.99 vs. QNTM: $17.06)
Brand notoriety: EBS and QNTM are both not notable
EBS represents the Pharmaceuticals: Other, while QNTM is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: EBS: 72% vs. QNTM: 116%
Market capitalization -- EBS: $120.07M vs. QNTM: $57.99M
EBS [@Pharmaceuticals: Other] is valued at $120.07M. QNTM’s [@Biotechnology] market capitalization is $57.99M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EBS’s FA Score shows that 1 FA rating(s) are green whileQNTM’s FA Score has 0 green FA rating(s).

  • EBS’s FA Score: 1 green, 4 red.
  • QNTM’s FA Score: 0 green, 5 red.
According to our system of comparison, EBS is a better buy in the long-term than QNTM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EBS’s TA Score shows that 4 TA indicator(s) are bullish while QNTM’s TA Score has 3 bullish TA indicator(s).

  • EBS’s TA Score: 4 bullish, 3 bearish.
  • QNTM’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, EBS is a better buy in the short-term than QNTM.

Price Growth

EBS (@Pharmaceuticals: Other) experienced а +2.34% price change this week, while QNTM (@Biotechnology) price change was -19.22% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

EBS is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EBS($120M) has a higher market cap than QNTM($58M). QNTM YTD gains are higher at: 363.587 vs. EBS (-26.883). QNTM has higher annual earnings (EBITDA): -20.68M vs. EBS (-518.2M). EBS has more cash in the bank: 112M vs. QNTM (3.54M). QNTM has less debt than EBS: QNTM (1.28M) vs EBS (860M). EBS has higher revenues than QNTM: EBS (1.02B) vs QNTM (0).
EBSQNTMEBS / QNTM
Capitalization120M58M207%
EBITDA-518.2M-20.68M2,506%
Gain YTD-26.883363.587-7%
P/E Ratio17.73N/A-
Revenue1.02B0-
Total Cash112M3.54M3,165%
Total Debt860M1.28M67,188%
FUNDAMENTALS RATINGS
EBS vs QNTM: Fundamental Ratings
EBS
QNTM
OUTLOOK RATING
1..100
5081
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
94100
PRICE GROWTH RATING
1..100
4834
P/E GROWTH RATING
1..100
11100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EBS's Valuation (57) in the Biotechnology industry is in the same range as QNTM (71) in the null industry. This means that EBS’s stock grew similarly to QNTM’s over the last 12 months.

EBS's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as QNTM (100) in the null industry. This means that EBS’s stock grew similarly to QNTM’s over the last 12 months.

EBS's SMR Rating (94) in the Biotechnology industry is in the same range as QNTM (100) in the null industry. This means that EBS’s stock grew similarly to QNTM’s over the last 12 months.

QNTM's Price Growth Rating (34) in the null industry is in the same range as EBS (48) in the Biotechnology industry. This means that QNTM’s stock grew similarly to EBS’s over the last 12 months.

EBS's P/E Growth Rating (11) in the Biotechnology industry is significantly better than the same rating for QNTM (100) in the null industry. This means that EBS’s stock grew significantly faster than QNTM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EBSQNTM
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
82%
Momentum
ODDS (%)
Bullish Trend 4 days ago
68%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
75%
Advances
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 17 days ago
83%
Declines
ODDS (%)
Bearish Trend 20 days ago
89%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
73%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 4 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KINS15.650.47
+3.10%
Kingstone Companies
TCI44.680.64
+1.45%
Transcontinental Realty Investors
AMNF8.250.05
+0.61%
Armanino Foods of Distinction, Inc.
PTJSF0.26N/A
N/A
PT Jasa Marga (Persero) TBK
IMDZF127.82N/A
N/A
IMCD NV

EBS and

Correlation & Price change

A.I.dvisor indicates that over the last year, EBS has been loosely correlated with AMRX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if EBS jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EBS
1D Price
Change %
EBS100%
-1.69%
AMRX - EBS
40%
Loosely correlated
+0.60%
HROW - EBS
40%
Loosely correlated
+3.86%
HKMPF - EBS
34%
Loosely correlated
N/A
SIGA - EBS
34%
Loosely correlated
N/A
VTRS - EBS
33%
Poorly correlated
-0.21%
More

QNTM and

Correlation & Price change

A.I.dvisor tells us that QNTM and CPIX have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that QNTM and CPIX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNTM
1D Price
Change %
QNTM100%
-10.96%
CPIX - QNTM
26%
Poorly correlated
-7.62%
EBS - QNTM
23%
Poorly correlated
-1.69%
RNA - QNTM
23%
Poorly correlated
-0.65%
ACB - QNTM
22%
Poorly correlated
+1.57%
ACLX - QNTM
22%
Poorly correlated
+1.24%
More